This study is testing whether a medication called olanzapine can help reduce opioid craving and misuse in people who are taking opioids for cancer pain. Olanzapine is a drug already used for other conditions. You might be able to join if you are 18 or older, have cancer pain, are currently taking opioids, and show signs of opioid misuse. The main goal is to see if olanzapine helps lower opioid craving. Researchers will also look at how it affects opioid misuse, the amount of opioids used, pain levels, and overall symptoms. The study aims to enroll 87 participants.

Study design

This is a double-blind, randomized control trial, meaning some participants will receive olanzapine and others a placebo (an inactive substance), and neither you nor your doctor will know which you are receiving. The study plans to include 87 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your safety and any side effects will be monitored throughout the study, which is expected to last an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.